Stemtech Corporation (STEK)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Vitamins & Nutrition Products	2.88M	5.05M	4.92M	4.56M	4.32M
Vitamins & Nutrition Products Growth	-43.08%	2.69%	7.94%	5.51%	-1.44%
Total	2.88M	5.05M	4.92M	4.56M	4.32M
Total Growth	-43.08%	2.69%	7.94%	5.51%	-1.44%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Americas	1.23M	2.17M	1.68M	1.55M	1.87M
Americas Growth	-43.27%	29.37%	8.33%	-17.10%	3.89%
Latin America	1.53M	2.67M	3.07M	2.50M	1.67M
Latin America Growth	-42.72%	-12.89%	22.54%	49.94%	3.07%
Asia	116.91K	215.26K	180.27K	510.93K	786.84K
Asia Growth	-45.69%	19.41%	-64.72%	-35.07%	-18.85%
Total	2.88M	5.05M	4.92M	4.56M	4.32M
Total Growth	-43.08%	2.69%	7.94%	5.51%	-1.44%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error